TELA Bio, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TELA Bio, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- TELA Bio, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- TELA Bio, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $46.34M.
- TELA Bio, Inc. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $0.00.
- TELA Bio, Inc. stock issued during period, value, new issues for fiscal 2023 was $46.34M, a 34.71% increase from fiscal 2022.
- TELA Bio, Inc. stock issued during period, value, new issues for fiscal 2022 was $34.40M, a 41851.22% increase from fiscal 2021.
- TELA Bio, Inc. stock issued during period, value, new issues for fiscal 2021 was $82.00K, a 99.82% decline from fiscal 2020.
- TELA Bio, Inc. stock issued during period, value, new issues for fiscal 2020 was $44.72M, a 11.67% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $46.34M 10-K · filed 2026-03-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | |
| 2023-06-30 | $46.34M 10-Q · filed 2024-08-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $34.40M 10-K · filed 2025-03-21 |
| 2022-09-30 | $34.40M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $82.00K 10-K · filed 2024-03-22 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $44.72M 10-K · filed 2023-03-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | |
| 2020-06-30 | $44.72M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $50.63M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |